FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA PUBLIC CALENDAR

This public calendar is issued by the Food and Drug Administration. It lists meetings held by the FDA policy makers with persons outside the executive branch of the Federal Government.

	July 5, 2005
FDA Official and Title	Date and Site	Other FDA Participants	Non-FDA Participants	Subject
Lester Crawford, Acting Commissioner Food and Drugs	6/22/05, Parklawn Bldg., Rockville, MD	Janet Woodcock	Ray Woosley, C-Path	Critical Path
Lester Crawford, Acting Commissioner Food and Drugs	6/22/05, Parklawn Bldg., Rockville, MD	Daniel Schultz, Susan Bond, and Wanda Russ	Guidant Corporation: Fred McCoy, Dale DeVries, Lynn Elliott, and Bernard Kury; King & Spalding LLP: Frederick Degnan, Edward Basile, Akin, Gump, Strauss; Hauer and Feld LLP: John Dowd; Johns Hopkins University: Ronald Berger	Classification of the Recall for Guidant Corporation's Implantable Defibrillators
Janet Woodcock, MD Deputy Commissioner for Operations	6/22/05 Washington, DC		Wendy Dixon Mark Smith Tami Lewis, RN	Patient Advocate Foundation
Janet Woodcock, MD Deputy Commissioner for Operations	6/27/05 Washington, DC		Theresa Musser Minnie Baylor – Henry Deborah Burns	Drug Information Association Annual Meeting
Janet Woodcock, MD Deputy Commissioner for Operations	6/29/05 Washington, DC		Bernadine Healy, MD Ronald D. Fitzmartin, PhD	Drug Information Association
Janet Woodcock, MD Deputy Commissioner for Operations	6/30/05 Washington, DC		University of Pennsylvania School of Medicine Duke University Medical Center	Institute of Medicine: Forum on Drug Discovery Development
Margaret Glavin, Associate Commissioner of Regulatory Affairs	6/23-24/05, Trip to Chicago	None	N/A	Presentation at the Chicago Stockyard
Jesse L. Goodman, MD, MPH, Director, CBER	6/24/05, Washington, D.C.	Karen Midthun, MD, Deputy for Medicine; Cecilia Witten, MD, Director, OCTGT; Mary Malarkey, Director, OCBQ (All CBER); other FDA attendees	Industry reps for tissue manufacturers	Update on new tissue regs; Dr. Goodman attended but did not speak
Jesse L. Goodman, MD, MPH, Director, CBER	6/27/05, Washington, D.C.	Mary Malarkey, Director, OCTGT, other staff	Abbott industry representatives	Issues regarding licensure of PRISM
Margaret Glavin, Associate Commissioner of Regulatory Affairs	6/27/05	None	Dino Cervantes and Andy Hatch/Advisory Group of USDA	Conference call with New Mexico and Advisory Group USDA/On a advisory board for USDA (fruits/veggies) - overlap between USDA and FDA - relates to risk management/risk assessment - would like to know the direction you (FDA) are going - information gathering call
Jesse L. Goodman, MD, MPH, Director, CBER	6/28/05, Washington, D.C.	Attendees	Registrants at DIA Annual Conference	CBER Updates
Margaret Glavin, Associate Commissioner of Regulatory Affairs	6/29/05	None	N/A	JFK Mail Facility
Lester Crawford, Acting Commissioner Food and Drugs	6/30/05, Parklawn Bldg., Rockville, MD	Daniel Schultz, Susan Bond, and Wanda Russ	Guidant Corporation: Fred McCoy, Dale DeVries, Lynn Elliott, and Bernard Kury; King & Spalding LLP: Frederick Degnan, Edward Basile, Akin, Gump, Strauss; Hauer and Feld LLP: John Dowd; Johns Hopkins University: Ronald Berger	/Classification of the Recall for Guidant Corporation's Implantable Defibrillators
Sheldon T. Bradshaw, Chief Counsel	Washington, D.C.	None	Marc Scheineson, Donald Segal, Robert Driscoll, and Alston & Bird	Introduction/Courtesy
Sheldon T. Bradshaw, Chief Counsel	Washington, D.C.	None	FDLI Members	Spoke at luncheon

Public Calendar Archives
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility

FDA Website Management Staff